The clinical promise of 18F-flurpiridaz PET imaging heralds a new frontier in the diagnosis and management of coronary artery disease

被引：0
|
作者：
Packard, Rene R. Sevag [1 ,2 ,3 ,4 ,5 ]
机构：
[1] Univ Calif Los Angeles, David Geffen Sch Med, Dept Med, Div Cardiol, Los Angeles, CA 90095 USA
[2] Univ Calif Los Angeles, David Geffen Sch Med, Dept Physiol, Los Angeles, CA 90095 USA
[3] Ronald Reagan Univ Calif Los Angeles, Med Ctr, Los Angeles, CA 90095 USA
[4] Los Angeles West Vet Affairs Med Ctr, Los Angeles, CA 90025 USA
[5] Univ Calif Los Angeles, Calif NanoSyst Inst, Los Angeles, CA 90095 USA
来源：
NATURE CARDIOVASCULAR RESEARCH | 2025年 / 4卷 / 01期
基金：
美国国家卫生研究院;
关键词：
POSITRON-EMISSION-TOMOGRAPHY; FLURPIRIDAZ F-18;
D O I：
10.1038/s44161-024-00587-w
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
The PET radiotracer F-18-flurpiridaz has undergone rigorous clinical testing and gained FDA approval for the evaluation of coronary artery disease. Its unique properties suggest F-18-flurpiridaz has the potential to transform the field of nuclear myocardial perfusion imaging and blood flow quantification, with far-reaching effects on cardiovascular care.
引用
收藏
页码：1 / 4
页数：4
相关论文
共 50 条
  • [1] Subendocardial quantification enhances coronary artery disease detection in 18F-flurpiridaz PET
    Builoff, Valerie
    Lemley, Mark
    Miller, Robert J. H.
    Fujito, Hidesato
    Ramirez, Giselle
    Kavanagh, Paul
    Buckley, Christopher
    Di Carli, Marcelo
    Berman, Daniel S.
    Slomka, Piotr
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2025,
  • [2] Added value of myocardial blood flow using 18F-flurpiridaz PET to diagnose coronary artery disease: The flurpiridaz 301 trial
    Jonathan B. Moody
    Alexis Poitrasson-Rivière
    Tomoe Hagio
    Christopher Buckley
    Richard L. Weinberg
    James R. Corbett
    Venkatesh L. Murthy
    Edward P. Ficaro
    Journal of Nuclear Cardiology, 2021, 28 : 2313 - 2329
  • [3] Added value of myocardial blood flow using 18F-flurpiridaz PET to diagnose coronary artery disease: The flurpiridaz 301 trial
    Moody, Jonathan B.
    Poitrasson-Riviere, Alexis
    Hagio, Tomoe
    Buckley, Christopher
    Weinberg, Richard L.
    Corbett, James R.
    Murthy, Venkatesh L.
    Ficaro, Edward P.
    JOURNAL OF NUCLEAR CARDIOLOGY, 2021, 28 (05) : 2313 - 2329
  • [4] EXERCISE FLOW RESERVE IMAGING WITH 18F-FLURPIRIDAZ PET RULES OUT HIGH-RISK OBSTRUCTIVE CORONARY ARTERY DISEASE
    Choueiry, Justen
    Wu, Kai Yi
    deKemp, Ella
    Kaps, Nicole
    Lazewatsky, Joel
    Beanlands, Rob S. B.
    deKemp, Robert
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2023, 81 (08) : 1408 - 1408
  • [5] Phase 2 clinical comparison of flurpiridaz F 18 injection PET and SPECT myocardial perfusion imaging for diagnosis of coronary artery disease
    Maddahi, Jamshid
    Berman, Daniel
    Taillefer, Raymond
    Udelson, James
    Devine, Marybeth
    Lazewatsky, Joel
    Bhat, Gajanan
    Washburn, Dana
    JOURNAL OF NUCLEAR MEDICINE, 2011, 52
  • [6] Impact of the kinetic model on diagnostic accuracy of MBF and MFR for coronary artery disease assessment using 18F-flurpiridaz PET
    Moody, Jonathan
    Poitrasson-Riviere, Alexis
    Hagio, Tomoe
    Renaud, Jennifer
    Murthy, Venkatesh
    Ficaro, Edward
    JOURNAL OF NUCLEAR MEDICINE, 2020, 61
  • [7] Phase 2 safety and clinical comparison of flurpiridaz F 18 injection PET and SPECT myocardial perfusion imaging for diagnosis of coronary artery disease
    Maddahi, J.
    Berman, D. S.
    Taillefer, R.
    Udelson, J.
    Devine, M.
    Lazewatsky, J.
    Bhat, G.
    Washburn, D.
    EUROPEAN HEART JOURNAL SUPPLEMENTS, 2011, 13 (0A) : A45 - A45
  • [8] Flurpiridaz F-18 PET Myocardial Perfusion Imaging in Patients With Suspected Coronary Artery Disease
    Maddahi, Jamshid
    Agostini, Denis
    Bateman, Timothy M.
    Bax, Jeroen J.
    Beanlands, Rob S. B.
    Berman, Daniel S.
    Dorbala, Sharmila
    V. Garcia, Ernest
    Feldman, James
    V. Heller, Gary
    Knuuti, Juhani M.
    Martinez-Clark, Pedro
    Pelletier-Galarneau, Matthieu
    Shepple, Benjamin
    Tamaki, Nagara
    Tranquart, Francois
    Udelson, James E.
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2023, 82 (16) : 1598 - 1610
  • [9] Optimization of imaging protocols for myocardial blood flow (MBF) quantification with 18F-flurpiridaz PET
    Wiyaporn, Kanyalak
    Tocharoenchai, Chiraporn
    Pusuwan, Pawana
    Higuchi, Takahiro
    Fung, George S. K.
    Feng, Tao
    Park, Min Jae
    Tsui, Benjamin M. W.
    PHYSICA MEDICA-EUROPEAN JOURNAL OF MEDICAL PHYSICS, 2017, 42 : 127 - 134
  • [10] Improved Assessment of Coronary Artery Disease in Obese Subjects with Flurpiridaz F18 PET Myocardial Perfusion Imaging: A Subgroup Analysis of the Flurpiridaz F-18 303 Phase 3 Study
    Patel, Krishna
    maddahi, Jamshid
    Agostini, Denis
    Bax, Jeroen
    Beanlands, Rob
    Berman, Daniel
    Dorbala, Sharmila
    Garcia, Ernest
    Feldman, James
    Heller, Gary
    Knuuti, Juhani
    Martinez-Clark, Pedro
    Pelletier-Galarneau, Matthieu
    Shepple, Benjamin
    Tamaki, Nagara
    Udelson, James
    Bateman, Timothy
    JOURNAL OF NUCLEAR MEDICINE, 2023, 64
12345